Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

An individualized conditional survival calculator for patients with rectal cancer.

Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ.

Dis Colon Rectum. 2013 May;56(5):551-9. doi: 10.1097/DCR.0b013e31827bd287.

2.

Practical application of a calculator for conditional survival in colon cancer.

Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA.

J Clin Oncol. 2009 Dec 10;27(35):5938-43. doi: 10.1200/JCO.2009.23.1860. Epub 2009 Oct 5.

PMID:
19805670
3.

An interactive tool for individualized estimation of conditional survival in rectal cancer.

Wang SJ, Wissel AR, Luh JY, Fuller CD, Kalpathy-Cramer J, Thomas CR Jr.

Ann Surg Oncol. 2011 Jun;18(6):1547-52. doi: 10.1245/s10434-010-1512-3. Epub 2011 Jan 5.

4.

Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.

Franklin RA, Giri S, Valasareddy P, Lands LT, Martin MG.

Clin Colorectal Cancer. 2016 Mar;15(1):47-53. doi: 10.1016/j.clcc.2015.07.007. Epub 2015 Aug 1.

PMID:
26362848
5.

Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.

Madbouly KM, Hussein AM, Abdelzaher E.

Am J Surg. 2014 Sep;208(3):332-41. doi: 10.1016/j.amjsurg.2013.10.023. Epub 2014 Jan 17.

PMID:
24581995
6.

Survival outcome of operated and non-operated elderly patients with rectal cancer: A Surveillance, Epidemiology, and End Results analysis.

Bhangu A, Kiran RP, Audisio R, Tekkis P.

Eur J Surg Oncol. 2014 Nov;40(11):1510-6. doi: 10.1016/j.ejso.2014.02.239. Epub 2014 Feb 28.

PMID:
24704032
7.

Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer.

Katz MH, Hu CY, Fleming JB, Pisters PW, Lee JE, Chang GJ.

Arch Surg. 2012 Jun;147(6):513-9. doi: 10.1001/archsurg.2011.2281.

8.

Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012).

Kim E, Kim JS, Choi M, Thomas CR Jr.

Dis Colon Rectum. 2016 Apr;59(4):291-8. doi: 10.1097/DCR.0000000000000555.

PMID:
26953987
9.

Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection.

Patel SA, Chen YH, Hornick JL, Catalano P, Nowak JA, Zukerberg LR, Bleday R, Shellito PC, Hong TS, Mamon HJ.

Dis Colon Rectum. 2014 Apr;57(4):449-59. doi: 10.1097/DCR.0b013e3182a70709.

10.
11.

Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma.

Chiu MS, Verma V, Bennion NR, Bhirud AR, Li J, Charlton ME, Are C, Lin C.

Cancer Med. 2016 Dec;5(12):3394-3402. doi: 10.1002/cam4.927. Epub 2016 Oct 26.

12.

Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study.

Lykke J, Jess P, Roikjaer O; Danish Colorectal Cancer Group.

Dis Colon Rectum. 2015 Sep;58(9):823-30. doi: 10.1097/DCR.0000000000000429.

PMID:
26252843
13.

Surgeon-related factors and outcome in rectal cancer.

Porter GA, Soskolne CL, Yakimets WW, Newman SC.

Ann Surg. 1998 Feb;227(2):157-67.

14.

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Rödel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, Ghadimi M, Wolff HA, Lang-Welzenbach M, Raab HR, Wittekind C, Ströbel P, Staib L, Wilhelm M, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R, Liersch T; German Rectal Cancer Study Group.

Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15.

PMID:
26189067
15.

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer.

van Dijk TH, Tamas K, Beukema JC, Beets GL, Gelderblom AJ, de Jong KP, Nagtegaal ID, Rutten HJ, van de Velde CJ, Wiggers T, Hospers GA, Havenga K.

Ann Oncol. 2013 Jul;24(7):1762-9. doi: 10.1093/annonc/mdt124. Epub 2013 Mar 22.

PMID:
23524865
16.

Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.

Modrek AS, Hsu HC, Leichman CG, Du KL.

Radiat Oncol. 2015 Apr 24;10:101. doi: 10.1186/s13014-015-0411-y.

17.

Neoadjuvant-intensified treatment for rectal cancer: time to change?

Musio D, De Felice F, Bulzonetti N, Guarnaccia R, Caiazzo R, Bangrazi C, Raffetto N, Tombolini V.

World J Gastroenterol. 2013 May 28;19(20):3052-61. doi: 10.3748/wjg.v19.i20.3052.

18.

Lymph node identification following neoadjuvant therapy in rectal cancer: A stage-stratified analysis using the surveillance, epidemiology, and end results (SEER)-medicare database.

Ecker BL, Paulson EC, Datta J, Jeganathan AN, Aarons C, Kelz RR, Mahmoud NN.

J Surg Oncol. 2015 Sep;112(4):415-20. doi: 10.1002/jso.23991. Epub 2015 Aug 6.

PMID:
26250884
19.

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.

Velenik V, Oblak I, Anderluh F.

Radiat Oncol. 2010 Sep 29;5:88. doi: 10.1186/1748-717X-5-88.

20.

Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.

Pacelli F, Sanchez AM, Covino M, Tortorelli AP, Bossola M, Valentini V, Gambacorta MA, Doglietto GB.

Am Surg. 2013 Feb;79(2):151-61.

PMID:
23336654

Supplemental Content

Support Center